Login / Signup

A Case of Immune-Related Aseptic Meningitis during Atezolizumab plus Bevacizumab for Hepatocellular Carcinoma.

Hiroki KawanakaKazuto TajiriNozomu MuraishiAiko MurayamaTakamasa NukuiIchiro Yasuda
Published in: Case reports in gastroenterology (2024)
Clinicians should monitor to avoid serious immune-related adverse events, such as aseptic meningitis, in patients during treatment of HCC with immune checkpoint inhibitors and make the diagnosis as soon as possible.
Keyphrases
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • cerebrospinal fluid
  • peritoneal dialysis
  • prognostic factors
  • palliative care
  • patient reported
  • metastatic colorectal cancer